At a glance
- Originator Alter
- Class Anti-ischaemics; Antihypertensives; Dihydropyridines; Neuroprotectants; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebellar diseases; Cerebral ischaemia
Most Recent Events
- 25 Jun 2001 No-Development-Reported for Brain dysfunction in Spain (Unknown route)
- 25 Jun 2001 No-Development-Reported for Cerebral ischaemia in Chile (Unknown route)
- 25 Jun 2001 No-Development-Reported for Cerebral ischaemia in Spain (Unknown route)